Objective: To present molecular cytogenetic characterization of a prenatally detected duplication of 15q26.2 / q26.3 in a fetus with overgrowth. Case Report: A 34-year-old para 0 woman underwent amniocentesis at 18 weeks of gestation because of advanced maternal age. Amniocentesis revealed a derivative chromosome 15, or der(15), with additional material at the end of the long arm of one chromosome 15. Parental karyotypes were normal. Fetal overgrowth was first noted at 21 weeks of gestation. Repeated amniocentesis was performed at 22 weeks of gestation. Array comparative genomic hybridization revealed a 4.71-Mb duplication from 15q26.2 to 15q26.3 encompassing the IGF1R gene. Fluorescence in situ hybridization analysis using the bacterial artificial chromosome clone probes specific for 15q26.2-q26.3 and the subtelomeric region of 15q showed a direct duplication and no terminal deletion in the der(15). Polymorphic DNA marker analysis determined a paternal origin of the duplication of 15q. Level II ultrasound at 23 weeks of gestation revealed a fetal biometry equivalent to 26 weeks. The pregnancy was subsequently terminated, and a 1062-g (>99 th centile) malformed fetus was delivered at 24 weeks of gestation with craniofacial dysmorphism, craniosynostosis, and overgrowth. Conclusion: The present case provides evidence for prenatal overgrowth, craniosynostosis, and characteristic facial dysmorphism in association with a duplication of 15q26.2 / q26.3 and a duplication of the IGF1R gene. Prenatal diagnosis of fetal overgrowth should include a differential diagnosis of the chromosome 15q overgrowth syndrome.
Introduction
The chromosome 15q overgrowth syndrome is an overgrowth syndrome caused by increased gene dosage of IGF1R through duplication or triplication of the 15q26.1-qter region involving 15q26.3 because of trisomy and tetrasomy of distal chromosome 15q [1] . This syndrome is characterized by the clinical features of overgrowth, learning difficulties, a characteristic facial appearance of a long thin face with a prominent chin and nose, and renal anomalies of renal agenesis, horseshoe kidneys, and hydronephrosis [1] . Prenatal diagnosis of the chromosome 15q overgrowth syndrome is unusual. Here we report prenatal diagnosis, molecular cytogenetic characterization, and perinatal findings in a fetus with a duplication of 15q26.2 / q26.3 and overgrowth.
Case report
A 34-year-old, gravid 2, para 0, woman underwent amniocentesis at 18 weeks of gestation because of her advanced maternal age. The woman had experienced two spontaneous abortions. Her husband was 35 years old. Cytogenetic analysis then revealed a derivative chromosome 15, or der(15), with additional material at the end of the long arm of one chromosome 15 (Fig. 1) (Fig. 2) . The result of oligo-aCGH was arr cgh 15q26.2q26.3 (95,490,272e100,200,967)Â3. For fluorescence in situ hybridization (FISH) determination of the orientation of the duplication and no terminal deletion in the der(15), the bacterial artificial chromosome (BAC) clone probes mapping the genomic region of 15q26.2-q26.3 and the subtelomeric region of 15q were used. The BAC clone probes RP11-308P12 (96,148,983e96,341,797) (spectrum green) and RP11-66B24 (99,149,459e99,322,865) (spectrum red) were used to determine the orientation of the duplication. FISH analysis showed an orientation of green-[(red-green) or yellow]-red consistent with the diagnosis of a direct duplication of distal 15q (Fig. 3) . The BAC clone probe RP11-259N2 (100,094,760e100,248,597) (spectrum green) was used to determine the presence of the subtelomeric region of the der (15) . FISH analysis showed no terminal deletion in the der (15) (Fig. 4) . The karyotype of the fetus was 46,XY,dup(15) (q26.2q26.3) (Fig. 1) . Level II ultrasound at 23 weeks of gestation revealed a fetal biometry equivalent to 26 weeks [BPD ¼ 6.7 cm (>99 th centile), abdominal circumference ¼ 21.6 cm (>99 th centile), and FL ¼ 4.56 cm (>99 th centile). The internal organs were unremarkable. The parents elected to terminate the pregnancy, and a 1062-g (>99 th centile) malformed fetus was delivered at 24 weeks of gestation. The fetus manifested macrocephaly, an elongated face, a sloping forehead, down-slanting palpebral fissures, hypertelorism, a down-turned mouth, and a prominent nose and chin (Fig. 5 ). Three-dimensional computed tomography scans of the skull showed premature synostosis of the metopic and coronal sutures (Fig. 6 ). Quantitative fluorescent polymerase chain reaction analysis using polymorphic DNA markers determined a paternal origin of the duplication ( Fig. 7 ) ( Table 1) .
Discussion
The present case had a direct duplication of 15q26.2 / q26.3 and a duplication of the IGF1R gene, and manifested prenatal overgrowth, craniosynostosis, and characteristic facial dysmorphism. Insulin-like growth factor 1 receptor [Online Mendelian Inheritance in Man (OMIM) 147370] is the receptor for type 1 insulin-like growth factor (IGF1) (OMIM 147440). The IGF1R gene is mapped to 15q26.3 and is involved in growth, insulin-related phenotypes, and longevity. The IGF1R gene is expressed equally from the maternal and paternal alleles in humans and has not been known to be imprinted [2, 3] . Insulin-like growth factor 1 receptor is required for normal fetal and postnatal growth. Gene dosage increase of IGF1R can lead to overgrowth, whereas gene dosage decrease of IGF1R can cause growth retardation. Okubo et al [4] reported accelerated growth of the skin fibroblasts in a tall child with three copies of the IGF1R gene and slower growth of the skin fibroblasts in a short child with one copy of the IGF1R gene. Faivre et al [5] observed a specific phenotype of macrosomia at birth, overgrowth, macrocephaly, and mild developmental delay in patients with trisomy 15q26.1-qter. Kant et al [6] reported tall stature and mental retardation in patients with trisomy 15q26-qter and a duplication of the IGF1R gene. Abuzzahab et al [7] postulated that mutations in the IGF1R gene may result in IGF1 resistance and underline intrauterine growth retardation and subsequent short stature. Bonafè et al [8] hypothesized that the polymorphic variants of IGF1R play a role in systemic IGF1 regulation and human longevity by down-regulating the IGF1 pathway or IGF1 plasma levels. Pure trisomy for distal 15q has been described in at least 15 patients [1,4,6,9e14] . In case of mixed or non-pure trisomy for distal 15q, the chromosome aberration has arisen from an unbalanced reciprocal translocation inherited from the parent and contains a deletion of another chromosome. The phenotype of such a case thus can be attributed to monosomy of the involved chromosome in addition to partial trisomy 15q. The reported monosomies associated with non-pure trisomy 15q include monosomic components of chromosomes 2q [6,15e18] , 12p [19] , 13q [5, 20, 21] , 14p [1] , 15p [1] , and 20p [5] . Inv dup del(15q) has been reported in one case [30] . Genesio et al [30] reported an inverted duplication of 15q and a terminal 15q deletion in a case with three copies of the IGF1R gene, marked intrauterine growth restriction, congenital heart defects, horseshoe kidneys, hand contractures, and club feet. In case of tetrasomy for distal 15q, the tetrasomy is the result of an acentric inverted duplication of distal 15q in the form of mosaic or nonmosaic distribution of an analphoid supernumerary marker chromosome [1,22e29] . To date, about 41 patients with trisomy or tetrasomy for distal 15q have been reported. Among the 41 reported cases with trisomy or tetrasomy for distal 15q, only six cases manifested craniosynostosis [15,19e21,25] . Our case adds to the list of trisomy or tetrasomy for distal 15q with craniosynostosis.
Prenatal diagnosis of fetal overgrowth should include a differential diagnosis of incorrect gestational dating; normal variants such as familial tall stature or familial rapid maturation; secondary overgrowth which is due to humorally mediated factors outside the skeletal system such as diabetic macrosomia or congenital nesidioblastosis; and primary overgrowth which is due to intrinsic cellular hyperplasia [31, 32] . Genetic considerations of primary overgrowth in prenatal-onset overgrowth include trisomy or tetrasomy for distal 15q or the chromosome 15q overgrowth syndrome [1] , proximal 4p deletion [33] , deletion or microdeletion of 9q22.3 involving PTCH1, the gene responsible for Gorlin syndrome (OMIM 109400) (autosomal dominant at 9q22.3) [34e37], duplication of 4p16.3 [38] , deletion of 22q13 [39, 40] , mosaic tetrasomy 12p or Pallister-Killian syndrome (OMIM 601803) (sporadic) [41e43], trisomy 12p [44] , Beckwith-Wiedemann syndrome (OMIM 130650) (imprinting defects, sporadic or autosomal dominant) caused by loss of methylation at maternal imprinting center 2 or differentially methylated region 2, paternal uniparental disomy 11p15.5, mutations in CDKN1C, gain of methylation at maternal imprinting center 1 or differentially methylated region 1, 11p15.5 chromosome translocation/inversion or duplication, or unknown etiology [45, 46] , Sotos syndrome (OMIM 117550) (sporadic or autosomal dominant at 5q35) caused by NSD1 disease-causing mutations, deletion or microdeletion of 5q35 [47, 48] , Weaver syndrome (OMIM 277590) (sporadic and autosomal dominant at 5q35) with some patients with mutations in the NSD1 gene [49] , Perlman syndrome (OMIM 267000) (autosomal recessive) [50, 51] [64] , and PTEN hamartoma tumor syndrome such as Bannayan-Riley-Ruvalcaba syndrome (OMIM 153480) (autosomal dominant at 10q23.31) [65, 66] and Proteus syndrome (OMIM 176920) (sporadic) [66, 67] , caused by mutations in the PTEN gene.
In conclusion, the present case provides evidence for prenatal overgrowth, craniosynostosis, and characteristic facial dysmorphism in association with a duplication of 15q26.2 / q26.3 and a duplication of the IGF1R gene. Prenatal diagnosis of fetal overgrowth should include a differential diagnosis of the chromosome 15q overgrowth syndrome. 
